meta-analysis | Q815382 |
scholarly article | Q13442814 |
P2093 | author name string | Li Zhang | |
Xinghua Long | |||
P2860 | cites work | Measuring inconsistency in meta-analyses | Q27860655 |
Meta-analysis in clinical trials | Q27860779 | ||
Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 | ||
Cancer susceptibility and the functions of BRCA1 and BRCA2 | Q28217784 | ||
Hallmarks of 'BRCAness' in sporadic cancers | Q29618825 | ||
Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer | Q33646285 | ||
Gene promoter methylation is associated with increased mortality among women with breast cancer | Q33848807 | ||
Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. | Q53390870 | ||
Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients. | Q53633156 | ||
Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients. | Q54344941 | ||
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. | Q54428093 | ||
BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer. | Q54477757 | ||
BRCA1 expression in triple negative sporadic breast cancers. | Q54656850 | ||
BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. | Q55267342 | ||
BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)- Ribose Polymerase Inhibitors | Q57239856 | ||
Gene-Expression Profiles in Hereditary Breast Cancer | Q57240053 | ||
Methylation of the BRCA1 gene in sporadic breast cancer | Q57390855 | ||
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer | Q60613940 | ||
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics | Q77340263 | ||
Methylation profiles in breast cancer | Q83299220 | ||
BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls | Q83609308 | ||
CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma | Q84275444 | ||
BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation | Q85113142 | ||
Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer | Q85921942 | ||
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy | Q86109919 | ||
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors | Q33896961 | ||
Methylation signature of lymph node metastases in breast cancer patients | Q34303360 | ||
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer | Q34493362 | ||
Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer | Q34584767 | ||
CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer | Q35064727 | ||
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer | Q35605804 | ||
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer | Q35713228 | ||
Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes | Q35791618 | ||
Hereditary breast and ovarian cancer: review and future perspectives | Q36311502 | ||
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer | Q36402747 | ||
Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls | Q36402760 | ||
Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. | Q36600205 | ||
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer | Q37219292 | ||
Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer | Q37284980 | ||
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment | Q37324446 | ||
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes | Q38547141 | ||
Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells | Q39043296 | ||
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy | Q40345138 | ||
Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer | Q42444119 | ||
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer | Q42474391 | ||
Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer | Q42480009 | ||
BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression | Q42509934 | ||
Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue | Q43281130 | ||
Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women. | Q43491831 | ||
Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population | Q43739327 | ||
Detection of gene promoter hypermethylation in fine needle washings from breast lesions. | Q44576291 | ||
Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer. | Q45352459 | ||
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors | Q45877410 | ||
BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC. | Q46204355 | ||
Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker | Q46375432 | ||
Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis | Q46950071 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 17869 | |
P577 | publication date | 2015-12-08 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies | |
P478 | volume | 5 |